• KU-60019: ATM Kinase Inhibition and Metabolic Adaptation ...

  2025-10-21

  Discover how KU-60019, a selective ATM kinase inhibitor, uncovers novel metabolic vulnerabilities and adaptive responses in glioma beyond radiosensitization. This comprehensive analysis provides unique insights into macropinocytosis-driven survival and advanced cancer research strategies.

• AZD0156 and ATM Kinase Inhibition: Unraveling DNA Repair,...

  2025-10-20

  Explore how AZD0156, a potent ATM kinase inhibitor, is redefining cancer therapy research by uncovering the interplay between DNA double-strand break repair, checkpoint modulation, and metabolic adaptation. This in-depth analysis uniquely bridges mechanistic biochemistry and translational opportunities, setting it apart from existing discussions.

• KU-55933: ATM Kinase Inhibition Unveils Metabolic Vulnera...

  2025-10-19

  Explore how KU-55933, a potent ATM kinase inhibitor, drives innovation in DNA damage response research by revealing metabolic vulnerabilities in cancer cells. This article uniquely connects ATM signaling, cell cycle arrest, and metabolic reprogramming, offering fresh insights for advanced cancer and rare disease applications.

• KU-60019: Unlocking Metabolic Vulnerabilities in Glioma v...

  2025-10-18

  Discover how KU-60019, a selective ATM kinase inhibitor, unveils novel metabolic vulnerabilities in glioma by integrating DNA damage response inhibition with advanced metabolic reprogramming. This article offers a unique framework for leveraging KU-60019 in cancer research beyond radiosensitization.

94 records 7/7 page Previous First page 上5页 67